|
|
|
International Clinical Trials
|
Over the past 10 years, the market value of the global pharmaceutical industry has more than doubled to $951 billion. In 2015, markets outside the US and Western Europe accounted for $362 billion, comprising approximately 38% of the total worldwide value (1).
There is no doubt about it: the healthcare industry has become truly global, and clinical trials are being delocalised to match. In fact, between 2005 and 2012, the largest annual growth in clinical trials occurred in Asian (30%) and Latin American/Caribbean (12%) regions (2).
As the clinical trials industry expands into emerging countries, protocols developed in one country are increasingly implemented in culturally and linguistically different locations. Competent and compliant translation is, therefore, becoming more necessary than ever in order to ensure that clinical trial protocols (CPTs) are correctly followed, and that participants can confidently understand and consent to them.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
MRC Technology monetises royalties on cancer drug Keytruda (pembrolizumab) to expand medical research activities, with a fund managed by DRI Capital
More info >> |
|
 |
White Papers |
 |
|
Stripping the confusion out of PVC curtains... and a new seat range.
Teknomek Ltd
With the ever-growing trend towards modularisation of clean rooms and laboratories; Teknomek have responded with a new range of PVC strip curtains, suitable for use in environments where maintaining clean airflow is critical. This new PVC curtain range includes specialist perforated and electrostatic discharge alternatives to the standard options of clear and polar (-25oC) versions.
More info >> |
|
 |
Industry Events |
 |
6th Annual Cancer Vaccines Conference
27-28 September 2017, Copthorne Tara Hotel, London UK
Cancer Vaccines 2017: Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies.
SMi Group is thrilled to present the 6th annual Cancer Vaccines conference, taking place on 27th & 28th September 2017 in Central London, UK. Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies.
More info >> |
|
|
